Hydrocephalus due to aqueductal stenosis presenting with acute bilateral ptosis: case report

2019 ◽  
Vol 34 (6) ◽  
pp. 683-685
Author(s):  
Mingxing Wu ◽  
Xiushan Ge ◽  
Yanbin Li ◽  
Jiye Li ◽  
Minglei Ma ◽  
...  
1985 ◽  
Vol 6 (2) ◽  
pp. 237-239 ◽  
Author(s):  
A. Rotilio ◽  
G. Salar ◽  
C. Dollo ◽  
C. Ori ◽  
A. Carteri

1944 ◽  
Vol 28 (10) ◽  
pp. 520-521 ◽  
Author(s):  
S. Gordon ◽  
B. H. Cragg
Keyword(s):  

2013 ◽  
Vol 91 ◽  
pp. 0-0
Author(s):  
B BATTA ◽  
F TRECHOT ◽  
V CLOCHE ◽  
T MAALOUF ◽  
K ANGIOI

2013 ◽  
Vol 2 (4) ◽  
pp. 168 ◽  
Author(s):  
Prabhas Giri ◽  
Priyankar Pal ◽  
Apurba Ghosh

1991 ◽  
Vol 54 (11) ◽  
pp. 1021-1021
Author(s):  
M Galeotti ◽  
P De Carolis ◽  
T Sacquegna ◽  
F S Finizio

2014 ◽  
pp. 330-331 ◽  
Author(s):  
Osman Okan Olcaysu ◽  
Ahmet Altun ◽  
Elif Olcaysu ◽  
Sertaç Argun Kıvanç ◽  
Zuhal Keskin Yıldırım
Keyword(s):  

2020 ◽  
Vol 5 (7) ◽  
pp. 190-193
Author(s):  
Dr. Usha BR. ◽  
◽  
Dr. Nandhini K ◽  
Dr. Chaitra MC ◽  
◽  
...  

Myasthenia gravis (MG) is a rare autoimmune disorder affecting neuromuscular junction by muscleweakness. Myasthenia gravis can be generalized or localized as ocular myasthenia gravis. Casepresentation: We report an 8-year-old boy who presented with 10 days history of drooping of botheyelids and 8 days history of diplopia. Examination revealed bilateral ptosis. A diagnosis of JuvenileOcular Myasthenia gravis was made when symptoms improved with intramuscular Edrophoniumadministration. He was commenced on oral Neostigmine at a dose of 2mg/Kg/ day,4 hourly individed doses and is on regular follow up and had a good response. Conclusion: Ocular Myastheniagravis (OMG) is a rare disease in itself. A high index of suspicion is required in a juvenile as it iseven rarer.


Sign in / Sign up

Export Citation Format

Share Document